During the past decade, Dallas Surgical Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dallas Surgical Group" #1 sponsor was "Saint John's Cancer Institute" with 2 trials, followed by "Agendia" with 1 trials sponsored, "Endomagnetics Inc" with 1 trials sponsored, "Juva Life" with 1 trials sponsored and "Precision Therapeutics" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dallas Surgical Group" #1 collaborator was "Melanoma Research Alliance" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator, "Regulatory and Clinical Research Institute Inc" with 1 trials as a collaborator and "Targeted Medical Education" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Dallas Surgical Group" are "Breast Cancer" (4 trials), "Breast Neoplasms" (2 trials), "Anxiety" (1 trials), "Appetite Disorders" (1 trials) and "Breast Diseases" (1 trials). Many other conditions were trialed in "Dallas Surgical Group" in a lesser frequency.

Most popular intervention types in "Dallas Surgical Group" are "Other" (5 trials), "Device" (2 trials), "Procedure" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BluePrint 80 gene expression profile" (1 trials), "ChemoFX Assay" (1 trials), "Completion Lymphadenectomy" (1 trials), "Genomic and/or molecular testing of blood or tissue" (1 trials) and "Isosulfan blue dye" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dallas Surgical Group" are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Dallas Surgical Group". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dallas Surgical Group, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dallas Surgical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".